Medical Equipment

C-Reactive Protein Testing Market 2025–2029: Tracking 5% CAGR Toward $4.28 Billion in Revenue

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the c-reactive protein testing market from 2025–2034 with trusted insights from The Business Research Company

How Will The C-Reactive Protein Testing Market Size Evolve Between Now And 2029?

The c-reactive protein testing market has shown consistent growth in its size over recent years. It is projected to expand from $3.45 billion in 2024 to reach $3.52 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 2.0%. The historical expansion of this market can be attributed to factors such as a greater prevalence of inflammatory diseases, the necessity for cardiovascular risk assessment, a growing aging demographic, enhancements in healthcare infrastructure, and the availability of healthcare screening programs.

The c-reactive protein testing market is projected to experience consistent expansion in the coming years. This market is forecast to reach $4.28 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.0%. Factors contributing to this growth over the forecast period include increasing obesity rates, the emergence of personalized medicine and biomarkers, expanded use of telehealth and remote monitoring, advancements in early disease detection, and the prevalence of lifestyle-related inflammation. Key trends anticipated during the forecast period encompass innovations in diagnostic testing, the rise of wearable health technology, novel technological solutions, significant strategic collaborations, and the adoption of Industry 4.0.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

Which Key Drivers Are Powering Growth In The C-Reactive Protein Testing Market?

The rising prevalence of cardiovascular diseases (CVD) is projected to propel the growth of the c-reactive protein testing market. Cardiovascular diseases include various heart conditions like diseased vessels, structural issues, and blood clots. Although the exact cause of CVD is uncertain, many factors can elevate the risk of its development. A key factor is behavioral risks stemming from unbalanced eating, insufficient physical activity, smoking, and alcohol consumption, which contribute to the accumulation of fatty deposits within the arteries (atherosclerosis) and a subsequent increased risk of blood clots. These behavioral risks also lead to elevated blood pressure, glucose, blood lipids, weight gain, and obesity. The increasing number of cardiovascular disease cases underscores the need for c-reactive protein testing to diagnose or predict the likelihood of cardiovascular problems with effectiveness at least on par with cholesterol level assessments. For example, in December 2023, according to the Institute for Health Metrics and Evaluation, global deaths from cardiovascular diseases (CVDs) reached 19.8 million in 2022, with ischemic heart disease being the leading cause at 108.8 deaths per 100,000 people. High systolic blood pressure was the main contributor to disability-adjusted life years (DALYs) related to CVD, while dietary risks and air pollution were significant behavioral and environmental factors driving this worldwide burden.

How Is The Global C-Reactive Protein Testing Market Structured By Key Segments?

The c-reactive protein testingmarket covered in this report is segmented –

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays

2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications

3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Subsegments:

1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA

2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems

3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

What Future-Focused Trends Are Anticipated In The C-Reactive Protein Testing Market?

A significant trend in the c-reactive protein testing market is the progression of technology in measuring instruments. Leading companies operating within the c-reactive protein testing market are concentrating on delivering cutting-edge solutions to enhance their standing. These firms are integrating next-generation c-reactive testing technologies into their methodologies and advanced solutions, which offer benefits such as maximum output and diverse applications. For example, in February 2022, Aidian, a Finnish-based diagnostic tests and test solutions company, introduced the QuikRead go wrCRP & wrCRP+Hb kits. This kit reliably yields two results, a wide range of CRP and Hb, from a single sample using a single analysis. The wide-range CRP test facilitates CRP readings for evaluating conditions like neonatal sepsis, forecasting disease severity in COPD (chronic obstructive pulmonary disease), and aiding in cardiovascular risk assessment.

Which Companies Hold A Competitive Edge In The C-Reactive Protein Testing Market?

Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Which Region Is Expected To Lead The C-Reactive Protein Testing Market In The Next Few Years?

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=6719&type=smp

Browse Through More Reports Similar to the Global C-Reactive Protein Testing Market 2025, By The Business Research Company

Protein Expression Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Therapeutic Proteins Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Orthobiologics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/orthobiologics-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795